Search research articles
Contact Us
Filters
Showing results (421-430 of 621) with videos related to
Page
of 63
Sort By:
Autoimmunity Reviews
|
December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
Camelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Rheumatology (Oxford, England)
|
August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
Dinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Rheumatology (Oxford, England)
|
November 22, 2022
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
Corrado Campochiaro, Anna-Maria Hoffmann-Vold, Jerome Avouac, et al.
BMJ Open
|
June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
Anna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
The Journal of Rheumatology
|
December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group
Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Rheumatology (Oxford, England)
|
October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Alain Lescoat, Dörte Huscher, Nils Schoof, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
Eric L Matteson, Clive Kelly, Jörg H W Distler, et al.
The European Respiratory Journal
|
October 15, 2021
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
Janine Schniering, Malgorzata Maciukiewicz, Hubert S Gabrys, et al.
Swiss Medical Weekly
|
January 24, 2022
Sarcoidosis - a multisystem disease
Daniel P Franzen, Martin Brutsche, Jakob Nilsson, et al.
Clinical and Experimental Rheumatology
|
October 18, 2016
Effects of rituximab in connective tissue disorders related interstitial lung disease
Gemma Lepri, Jerome Avouac, Paolo Airò, et al.
Page
of 63
Search research articles
Search
Showing results (421-430 of 621) with videos related to
Sort By:
Page
of 63
Autoimmunity Reviews
|
December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
Camelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Rheumatology (Oxford, England)
|
August 16, 2014
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
Dinesh Khanna, Daniel E Furst, Yannick Allanore, et al.
Rheumatology (Oxford, England)
|
November 22, 2022
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis
Corrado Campochiaro, Anna-Maria Hoffmann-Vold, Jerome Avouac, et al.
BMJ Open
|
June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
Anna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
The Journal of Rheumatology
|
December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group
Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Rheumatology (Oxford, England)
|
October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Alain Lescoat, Dörte Huscher, Nils Schoof, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
Eric L Matteson, Clive Kelly, Jörg H W Distler, et al.
The European Respiratory Journal
|
October 15, 2021
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
Janine Schniering, Malgorzata Maciukiewicz, Hubert S Gabrys, et al.
Swiss Medical Weekly
|
January 24, 2022
Sarcoidosis - a multisystem disease
Daniel P Franzen, Martin Brutsche, Jakob Nilsson, et al.
Clinical and Experimental Rheumatology
|
October 18, 2016
Effects of rituximab in connective tissue disorders related interstitial lung disease
Gemma Lepri, Jerome Avouac, Paolo Airò, et al.
Page
of 63